TR201000685A2 - Salmeterol ve flutikazon içeren farmasötik preparatlar. - Google Patents

Salmeterol ve flutikazon içeren farmasötik preparatlar.

Info

Publication number
TR201000685A2
TR201000685A2 TR2010/00685A TR201000685A TR201000685A2 TR 201000685 A2 TR201000685 A2 TR 201000685A2 TR 2010/00685 A TR2010/00685 A TR 2010/00685A TR 201000685 A TR201000685 A TR 201000685A TR 201000685 A2 TR201000685 A2 TR 201000685A2
Authority
TR
Turkey
Prior art keywords
forms
fluticasone
pharmaceutical preparations
preparations containing
salmeterol
Prior art date
Application number
TR2010/00685A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/00685A priority Critical patent/TR201000685A2/tr
Priority to PCT/TR2011/000020 priority patent/WO2011093818A2/en
Publication of TR201000685A2 publication Critical patent/TR201000685A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, salmeterol ve flutikazon ve/veya bunların farmasötik açıdan kabul edilebilir hidratları, enantiomerleri, rasematları, organik tuzları, inorganik tuzları, esterleri, polimorfları, kristal formları ve amorf formları ve/veya serbest bazı formunda ve/veya bunların kombinasyonundan oluşan, kuru toz formundaki farmasötik kompozisyonlara ve bunları içeren kapsül formlarına ilişkindir.
TR2010/00685A 2010-01-29 2010-01-29 Salmeterol ve flutikazon içeren farmasötik preparatlar. TR201000685A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/00685A TR201000685A2 (tr) 2010-01-29 2010-01-29 Salmeterol ve flutikazon içeren farmasötik preparatlar.
PCT/TR2011/000020 WO2011093818A2 (en) 2010-01-29 2011-01-28 Pharmaceutical compositions comprising salmeterol and fluticasone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00685A TR201000685A2 (tr) 2010-01-29 2010-01-29 Salmeterol ve flutikazon içeren farmasötik preparatlar.

Publications (1)

Publication Number Publication Date
TR201000685A2 true TR201000685A2 (tr) 2011-08-22

Family

ID=44141818

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00685A TR201000685A2 (tr) 2010-01-29 2010-01-29 Salmeterol ve flutikazon içeren farmasötik preparatlar.

Country Status (2)

Country Link
TR (1) TR201000685A2 (tr)
WO (1) WO2011093818A2 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2494730C1 (ru) * 2012-03-27 2013-10-10 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения болезней органов дыхания, содержащий в качестве активных веществ микронизированный салметерол ксинофоат и микронизированный флутиказона пропионат и способ его получения
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
CA2872845C (en) 2012-05-08 2021-11-09 Aciex Therapeutics, Inc. Preparation of nanocrystals of fluticasone propionate
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US20160129207A1 (en) * 2013-06-17 2016-05-12 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation composition filling method
WO2022045994A1 (en) * 2020-08-28 2022-03-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81976B (en) 1980-02-15 1982-07-28 Glaxo Group Ltd Androstane carbothioates
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB9924992D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Pharmaceutical aerosol formulations
GB0105560D0 (en) * 2001-03-07 2001-04-25 Glaxo Group Ltd Pharmaceutical formulations
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination
WO2005044187A2 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same

Also Published As

Publication number Publication date
WO2011093818A3 (en) 2012-02-23
WO2011093818A2 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
CY1122384T1 (el) Φαρμακοτεχνικες μορφες απιξαμπανης
PH12014502363A1 (en) N-aryltriazole compounds as lpar antagonists
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
CU20150020A7 (es) Composición farmacéutica recubierta que contiene regorafenib
TR201000685A2 (tr) Salmeterol ve flutikazon içeren farmasötik preparatlar.
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
IN2014DN09347A (tr)
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
TN2016000061A1 (en) Amide derivatives as lysophosphatidic acid receptor antagonists
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida
IL225105A (en) Heterocyclic compounds, their process, their pharmaceutical preparations and their use in the preparation of drugs
WO2015002755A3 (en) Compounds for the treatment of malaria
TR201005325A2 (tr) Atorvastatin ve aspirin içeren farmasötik formülasyonlar
MX2015001657A (es) Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar).
TR201000689A1 (tr) Sefprozil içeren katı dozaj formlar.
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
WO2013008253A3 (en) Imatinib formulations
WO2014160143A3 (en) Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
EA201301136A2 (ru) Новый способ синтеза (2e)-3-(3,4-диметоксифенил)проп-2-еннитрила, применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
TR201000682A2 (tr) Formoterol ve flutikazon içeren farmasötik preparatlar.
TR201000728A2 (tr) Formoterol ve flutikazon içeren farmasötik preparatlar.
CY1118132T1 (el) ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ (1R,4R)-6'-ΦΘΟΡΟ-Ν,Ν-ΔΙΜΕΘΥΛ-4-ΦΑΙΝΥΛ-4',9'-ΔΙΥΔΡΟ-3´H-ΣΠΕΙΡΟ-[ΚΥΚΛΟΕΞΑΝΟ-1,1'-ΠΥΡΑΝΟ[3,4,b]ΙΝΔΟΛ]-4-ΑΜΙΝΗΣ
TR200907914A2 (tr) Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
TR201000726A2 (tr) Formoterol ve siklesonit içeren blister formları